Advocate and lobby state Medicaid agencies and legislatures for adequate procedure payment

Collate and summarize existing clinical and economic evidence to support product positioning

Support the development of tools and messaging to advocate for comprehensive coverage and adequate payment rates; including, dossiers, budget impact models, reimbursement guides, etc

Work closely and in alignment to US commercial colleagues in sales and marketing

Communicate evidence requirements and reimbursement landscape to internal stakeholders

Monitor, analyze, and influence health care policy to ensure policy environment supports medical innovation

Provide training and education programs on reimbursement best practices and health policy issues to internal stakeholders and provide training and education to the sales force, physicians, office administrators and hospital personnel

Develops relationships with professional societies, medical associations, advocacy groups, thought leaders and trade groups for the purposes of driving comprehensive coverage and adequate payment of LivaNova products and procedures

This role requires about 25% travel

30:T2ef3,{"@context":"https://schema.org","@type":"JobPosting","title":"Manager, Market Access","description":"

Join us today and make a difference in people's lives!

LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improving the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems. The company is listed on the NASDAQ stock exchange under the ticker symbol \" LIVN .\" LivaNova is headquartered in London (UK) with a presence in over 100 countries and a team of more than 3,000 employees worldwide.

LivaNova Neuromodulation

As pioneers of the VNS (Vagus Nerve Stimulation) Therapy system, LivaNova continues to advance medical device solutions for patients affected by Drug-Resistant Epilepsy (DRE) and Difficult-to-Treat Depression (DTD). There are 3 million people in the U.S. alone and one on three people with epilepsy are drug resistant. People with severe seizures have, on average, a shorter life expectancy and an increased risk of cognitive impairment particularly if the seizures developed in early childhood. VNS Therapy for DRE is delivered through a device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to prevent seizures.

Position Summary

The Manager supports Market Access and Reimbursement across LivaNova businesses in the US. Position responsibilities pertain to key existing and new technologies in Neuromodulation, Cardiopulmonary and any ventures LivaNova may pursue. The role involves relationship development with hospitals administrators, physicians and surgeon providers, commercial payers, Medicare and its contractors, state legislators and Medicaid administrators. A major focus of this role involves supporting and educating providers on billing and coding and engaging commercial and governmental payers of healthcare in the US for comprehensive coverage and adequate payment of LivaNova technologies and procedures.

The successful candidate must demonstrate strong communication and collaboration skills and competence in reimbursement, health economics and coverage for medical devices in the US.

POSITION RESPONSIBILITIES

Support advocacy efforts with commercial and governmental payers for a defined region or assigned payers on the coverage and payment adequacy of LivaNova associated procedures and technologies.
Advocates for optimal coverage policies for LivaNova products and procedures with commercial and government payers
Advocate and lobby state Medicaid agencies and legislatures for adequate procedure payment.
Collate and summarize existing clinical and economic evidence to

Manager, Market Access

Job Type